PTX3 and central nervous system cancer: The absence of significant correlation in lower-grade gliomas (G2) and IDH-mutant cases suggests that the prognostic significance of PTX3 is more pronounced in aggressive tumor phenotypes, warranting further investigation into its mechanistic role in glioma pathophysiology.